Clinical Trial Update: Safety and Efficacy of Varying Methods of ALV003 Administration for the Treatment of Celiac Disease [Phase 2]

View source ↗

Summary

Phase 2 trial results report the safety and efficacy of varying ALV003 administration methods for the treatment of celiac disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• ALV003

Snippet

Sponsor: Alvine Pharmaceuticals Inc. | Conditions: Celiac Disease | Phase 2 | Status: COMPLETED